Cargando…
The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer
Treatment guidelines recommend that curative radiation treatment of prostate cancer be offered only to men whose life expectancy is greater than 10 years. The average life expectancy of North American males is less than 10 years after age 75, yet many men older than 75 years receive curative radiati...
Autores principales: | Blood, Paul A, Pickles, Tom |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1887532/ https://www.ncbi.nlm.nih.gov/pubmed/17511871 http://dx.doi.org/10.1186/1748-717X-2-17 |
Ejemplares similares
-
Exposure to statins post localized prostate cancer diagnosis and risk of metastasis among men who did not receive curative prostate cancer treatment
por: Habeshian, Talar S., et al.
Publicado: (2022) -
Potential overtreatment among men aged 80 years and older with localized prostate cancer in Japan
por: Masaoka, Hiroyuki, et al.
Publicado: (2017) -
Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men
por: Dankner, Rachel, et al.
Publicado: (2016) -
Long‐term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years old
por: Blas, Leandro, et al.
Publicado: (2021) -
Ready for 80 more years
por: de Olival Costa, Henrique Olavo
Publicado: (2015)